Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$30.58 -0.17 (-0.55%)
At close: Oct 21, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Receivables - Net (2013 - 2026)

Updated

Lakefront Biotherapeutics (LKFT) posted Receivables - Net of $25.45 million for the quarter ended Mar 31, 2026, down 52.7% from $53.8 million a year earlier but up 5.6% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Receivables - Net (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Lakefront Biotherapeutics' Receivables - Net came in at $23.39 million, down 54.5% from the prior year.

  • Annual Receivables - Net shows a five-year compound annual growth rate of -83.1% (years ended Dec 2020 to Dec 2025).
  • In prior years, Lakefront Biotherapeutics' Receivables - Net was $51.39 million in the year ended Dec 31, 2024 (+67.9%), $30.61 million in the year ended Dec 31, 2023 (-99.9%), $42.61 billion in the year ended Dec 31, 2022 (-67.7%) and $131.76 billion in the year ended Dec 31, 2021 (-22.2%).
  • Quarterly Receivables - Net has run from a low of $24.1 million in the quarter ended Dec 31, 2025 to a high of $127.37 billion in the quarter ended Dec 31, 2021 over five years.
  • On a year-over-year basis, Receivables - Net increased in two of the last six quarters, with an average decline of 7.5%.
  • The strongest year-over-year quarter for Receivables - Net in the past five years was the quarter ended Jun 30, 2021, with growth of 207.4%; the weakest was the quarter ended Dec 31, 2023, with a decline of 99.9%.
  • According to Business Quant data, Receivables - Net for the three prior quarters was $24.1 million (quarter ended Dec 31, 2025), $52.99 million (quarter ended Sep 30, 2025) and $62.82 million (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Lakefront Biotherapeutics 2.01 Bn 2.01 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 24.91 Mn
Dec 31, 2025 24.32 Mn
Sep 30, 2025 53.18 Mn
Jun 30, 2025 65.09 Mn
Mar 31, 2025 55.36 Mn
Dec 31, 2024 49.40 Mn
Sep 30, 2024 50.74 Mn
Mar 31, 2024 58.95 Mn
Dec 31, 2023 31.49 Mn
Sep 30, 2023 49.56 Mn
Mar 31, 2023 45.19 Mn
Dec 31, 2022 43.10 Mn
Mar 31, 2022 68.86 Mn
Dec 31, 2021 126.09 Mn
Jun 30, 2021 104.90 Mn
Dec 31, 2020 182.55 Mn
Jun 30, 2020 35.26 Mn
Mar 31, 2020 29.89 Mn
Dec 31, 2019 60.50 Mn
Sep 30, 2019 35.72 Mn
API Access

Lakefront Biotherapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=LKFT&period=max&api_key=YOUR_API_KEY